Cardioxyl Pharmaceuticals Raises $28 Million in Venture Funding
11/8/2012 9:07:45 AM
More...
|
Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session
4/5/2011 6:53:14 AM
More...
|
Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session
4/4/2011 2:23:51 PM
More...
|
Cardioxyl Pharmaceuticals Strengthens Executive Team by Appointing James Gilbert, M.D., as Chief Medical Officer
1/11/2011 6:42:29 AM
More...
|
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
8/26/2010 8:47:15 AM
More...
|
Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients; Cardioxyl Also Secures an Additional $15 Million in Funding
8/2/2010 7:05:37 AM
More...
|
Cardioxyl Pharmaceuticals' Data Presented at American College of Cardiology Annual Scientific Sessions
4/1/2010 9:49:34 AM
More...
|
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020 at American Heart Association Scientific Sessions 2009
11/18/2009 10:12:03 AM
More...
|
Cardioxyl Pharmaceuticals Announces Late Breaker at American Heart Association Conference
10/29/2009 11:58:11 AM
More...
|
Evotec AG (EVTG.F) Achieves Milestone With Cardioxyl Pharmaceuticals - as Compound Enters the Clinic
10/1/2009 8:51:13 AM
More...
|
|